{"id":538342,"date":"2026-06-29T22:51:27","date_gmt":"2026-06-29T22:51:27","guid":{"rendered":"https:\/\/www.newjerseyheadlines.com\/news\/story\/538342\/high-patient-volume-expected-at-new-surgery-center-for-specialized-healthcare-provider-expanding-throughout-southeast-and-midatlantic-region-cardiff-lexington-corporation-stock-symbol-cdix.html"},"modified":"2026-06-29T22:51:27","modified_gmt":"2026-06-29T22:51:27","slug":"high-patient-volume-expected-at-new-surgery-center-for-specialized-healthcare-provider-expanding-throughout-southeast-and-midatlantic-region-cardiff-lexington-corporation-stock-symbol-cdix","status":"publish","type":"post","link":"http:\/\/www.northcarolinaheadlines.com\/news\/story\/538342\/high-patient-volume-expected-at-new-surgery-center-for-specialized-healthcare-provider-expanding-throughout-southeast-and-midatlantic-region-cardiff-lexington-corporation-stock-symbol-cdix.html","title":{"rendered":"High Patient Volume Expected at New Surgery Center for Specialized Healthcare Provider Expanding Throughout Southeast and Mid-Atlantic Region: Cardiff Lexington Corporation (Stock Symbol: CDIX)"},"content":{"rendered":"<div style=\"float:right;width:250px;padding:8px 10px 10px 10px\"><a rel=\"nofollow noopener\" href=\"https:\/\/www.globalnewslines.com\/uploads\/2026\/06\/1782676627.jpg\" style=\"border:none !important\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-29\" title=\"High Patient Volume Expected at New Surgery Center for Specialized Healthcare Provider Expanding Throughout Southeast and Mid-Atlantic Region: Cardiff Lexington Corporation (Stock Symbol: CDIX)\" src=\"https:\/\/www.globalnewslines.com\/uploads\/2026\/06\/1782676627.jpg\" alt=\"High Patient Volume Expected at New Surgery Center for Specialized Healthcare Provider Expanding Throughout Southeast and Mid-Atlantic Region: Cardiff Lexington Corporation (Stock Symbol: CDIX)\" width=\"225\" height=\"159\" \/><\/a><\/div>\n<div style=\"clear:both\"><\/div>\n<div style=\"font-style:italic;padding:8px 0px\">$CDIX Now Operates a Total of 12 Surgical Centers Dedicated to Orthopedics, Spine Care and Pain Management<\/div>\n<ul style=\"text-align: justify\">\n<li><em>Focus on Acquiring and Building Middle-Market Niche Health Care Clinics, Primarily in Orthopedics, Spine Care and Pain Management.<\/em><\/li>\n<\/ul>\n<ul style=\"text-align: justify\">\n<li><em>Operating Nova Ortho and Spine, LLC, with a Network of Regional Specialty and Ancillary Orthopedic Care Centers Across Florida and Georgia.<\/em><\/li>\n<\/ul>\n<ul style=\"text-align: justify\">\n<li><em>Providing Traumatic Injury Patients with Comprehensive Diagnostic &amp; Surgical Services, Evaluations, Pain Management and Consultations.<\/em><\/li>\n<\/ul>\n<ul style=\"text-align: justify\">\n<li><em>Southeastern Surgery Center in Tallahassee, FL Adds High Visibility Metropolitan Location with Potential for High Patient Volume.<\/em><\/li>\n<\/ul>\n<ul style=\"text-align: justify\">\n<li><em>12 Surgical Center Established in Strategy to Expand Network Throughout Southeast and Mid-Atlantic Region.<\/em><\/li>\n<\/ul>\n<ul style=\"text-align: justify\">\n<li><em>Medical Office in Stuart, Florida to Serve the Strongly Growing Treasure Coast Community.<\/em><\/li>\n<\/ul>\n<ul style=\"text-align: justify\">\n<li><em>First Quarter Gross Profit was $1.3 Million, or 59.3% of Total Revenue.<\/em><\/li>\n<\/ul>\n<ul style=\"text-align: justify\">\n<li><em>Completed Upgrade to OTCQX Best Market, Highest Level of the OTC Markets.<\/em><\/li>\n<\/ul>\n<ul style=\"text-align: justify\">\n<li><em>Future Uplisting Plans to a National Securities Exchange, such as the NYSE American or Nasdaq Capital Market.<\/em><\/li>\n<\/ul>\n<p style=\"text-align: justify\"><strong><br \/>Cardiff Lexington Corporation (Stock Symbol: CDIX)<\/strong> is a targeted healthcare holding company dedicated to acquiring and building middle-market niche health care clinics, primarily in Orthopedics, Spine Care, and Pain Management. The <strong>CDIX<\/strong> partnership-driven culture emphasizes service excellence, teamwork, accountability, and performance.<\/p>\n<p style=\"text-align: justify\">All current <strong>CDIX<\/strong> revenue is derived from Nova Ortho and Spine, LLC, which operates a network of regional specialty and ancillary orthopedic care centers across Florida and Georgia. These facilities provide traumatic injury patients with comprehensive diagnostic and surgical services, primary care evaluations, interventional pain management, and specialty consultations.<\/p>\n<p style=\"text-align: justify\"><img decoding=\"async\" src=\"https:\/\/www.globalnewslines.com\/uploads\/2026\/06\/09b173643e5667c4ec3217121ac8f6ab.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify\"><strong>Addition of Southeastern Surgery Center in Tallahassee, Florida to Nova Ortho and Spine Network<\/strong><\/p>\n<p style=\"text-align: justify\">On June 29th<strong> CDIX <\/strong>announced that its Nova Ortho and Spine subsidiary has added Southeastern Surgery Center in Tallahassee, Florida to its growing network of surgical facilities, enhancing access to advanced orthopedic and spine care for patients in this region.<\/p>\n<p style=\"text-align: justify\">Southeastern Surgery Center has earned a strong reputation over many years of operation, recognized for its commitment to exceptional patient care, outstanding patient satisfaction, and stringent patient safety standards. <strong>CDIX<\/strong> Nova Ortho and Spine has begun performing minimally invasive pain management and spine procedures at Southeastern Surgery Center. These advanced procedures offer patients shorter recovery times, and less postoperative discomfort. The practice plans to expand its surgical offerings at the facility to include open procedures in the near future.<\/p>\n<p style=\"text-align: justify\">Alex Cunningham, Chief Executive Officer of <strong>CDIX<\/strong>, commented, &#8220;The addition of Southeastern Surgery Center as the 12th surgical center in the Nova Ortho and Spine network aligns perfectly with our long-term strategy to provide best in class patient-centered care to underserved populations. As the capital city of Florida, Tallahassee represents a strategic metropolitan location with high patient volume and visibility. This is a natural next step in our continued expansion in the southeast US and mid-Atlantic.&#8221;<\/p>\n<p style=\"text-align: justify\"><strong>Medical Office in Stuart, Florida to Serve the Growing Treasure Coast Community<\/strong><\/p>\n<p style=\"text-align: justify\">On May 20th<strong> CDIX <\/strong>announced that Nova Ortho and Spine, a wholly owned subsidiary, has opened a new location in Stuart, Florida. This new location further strengthens the <strong>CDIX<\/strong> Nova Ortho and Spine&#8217;s expanding regional network of healthcare facilities throughout Florida and supports the organization&#8217;s broader strategy of increasing accessibility to specialized orthopedic and spine services in underserved and high-growth markets.<\/p>\n<p style=\"text-align: justify\">Strategically positioned along the Federal Highway corridor with convenient access to major regional transportation routes, the newly developed 2,975-square-foot clinic expands Nova the <strong>CDIX <\/strong>Ortho and Spine&#8217;s footprint along Florida&#8217;s Treasure Coast and will provide comprehensive orthopedic, spine, and musculoskeletal care services to patients throughout Stuart, Palm City, Jensen Beach, Port St. Lucie, and surrounding Martin and St. Lucie County communities. The facility is designed to provide efficient patient flow, modern clinical infrastructure, and a patient-centered care environment focused on orthopedic evaluation, spine care, diagnostics, and non-surgical treatment options.<\/p>\n<p style=\"text-align: justify\">According to recent regional demographic estimates, the combined population of Martin and St. Lucie Counties now exceeds 650,000 residents, with continued growth projected over the coming decade. The Treasure Coast region also maintains one of Florida&#8217;s highest concentrations of residents aged 55 and older &#8211; a demographic frequently requiring orthopedic, spine, pain management, and mobility-related healthcare services.<\/p>\n<p style=\"text-align: justify\"><strong>First Quarter 2026 Financial Results<\/strong><\/p>\n<p style=\"text-align: justify\">On May 19th<strong> CDIX <\/strong>announced financial results for the first quarter ended March 31, 2026.<\/p>\n<p style=\"text-align: justify\">Alex Cunningham, Chief Executive Officer of <strong>CDIX<\/strong>, commented, &#8220;We continue to strengthen and expand our network of Nova Ortho and Spine locations to support growing patient demand with a focus on more high value procedures, and we remain confident in our ability to build a scalable platform through organic growth and acquisitions that deliver exceptional outcomes for patients. Furthermore, our recent upgrade to the OTCQX market represents an important step in increasing our visibility and credibility among institutional investors as we execute our strategic initiatives to enhance our access to working capital and drive sustainable, long-term growth and shareholder value.&#8221;<\/p>\n<p style=\"text-align: justify\"><strong>CDIX<\/strong> Total Revenue was $2.2 million compared with $2.9 million in the first quarter of 2025. The decrease in revenue is mainly attributable to a decrease in surgical procedures in the first quarter of 2026 compared to the first quarter of 2025.<\/p>\n<p style=\"text-align: justify\">Gross profit was $1.3 million, or 59.3% of total revenue, compared with $1.8 million, or 63.1% of total revenue in the first quarter of 2025.<\/p>\n<p style=\"text-align: justify\"><strong>CDIX<\/strong> Cash totaled $684,000 as of March 31, 2026.<\/p>\n<p style=\"text-align: justify\"><strong>CDIX<\/strong> Total Assets increased 4.1% to $30.3 million as of March 31, 2026.<\/p>\n<p style=\"text-align: justify\"><strong>Upgrade to OTCQX Best Market<\/strong><\/p>\n<p style=\"text-align: justify\">On April 9th<strong> CDIX<\/strong> announced that its common stock has been approved to trade on the OTCQX&reg; Best Market, the highest-level market of the OTC Markets.<\/p>\n<p style=\"text-align: justify\">The OTCQX Best Market is designed for established, investor-focused companies and requires high financial standards, strong corporate governance, and compliance with applicable securities laws.<\/p>\n<p style=\"text-align: justify\">Upgrading to OTCQX from the OTCQB&reg; Venture Market reflects the <strong>CDIX<\/strong> continued commitment to enhanced transparency and maintaining the highest governance and financial reporting standards available to companies trading on the OTC Markets.<\/p>\n<p style=\"text-align: justify\"><strong>CDIX<\/strong> has demonstrated consistent financial growth and operating performance driven by its focused healthcare platform strategy.<\/p>\n<p style=\"text-align: justify\"><strong>CDIX<\/strong> performance reflects a high-margin operating model within the orthopedic and spine care sector and underscores management&#8217;s focus on scalable, capital-efficient growth.<\/p>\n<p style=\"text-align: justify\"><img decoding=\"async\" src=\"https:\/\/www.globalnewslines.com\/uploads\/2026\/06\/9e55fc8dcd8511e007b975f7851788b7.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify\">Execution of Proven Three-Pillar Growth Strategy<\/p>\n<p style=\"text-align: justify\"><strong>CDIX<\/strong> continues to execute on its differentiated three-pillar strategy, designed to drive sustainable revenue growth, expand margins, and enhance long-term shareholder value:<\/p>\n<p style=\"text-align: justify\">Core Cash Flow Platform &#8211; Acquisition and optimization of physician orthopedic and related practices to generate consistent, recurring revenue streams<\/p>\n<p style=\"text-align: justify\">Asset Acquisition &#8211; Strategic acquisition of ambulatory surgery centers (ASCs), MRI Clinics, and clinic real estate to enhance operating leverage and asset-backed value<\/p>\n<p style=\"text-align: justify\">Finance Strategy &#8211; Retention and management of personal injury-related accounts receivable to maximize long-term cash yield versus discounted third-party sales<\/p>\n<p style=\"text-align: justify\">This integrated approach has enabled <strong>CDIX <\/strong>to establish a high-margin operating model within a fragmented and supply-constrained healthcare segment, positioning it for disciplined expansion through both organic growth and targeted acquisitions in one of the most resilient segments of U.S. Healthcare that offers an exceptional balance of downside protection, sustainable profitability, and scalable growth.<\/p>\n<p style=\"text-align: justify\">The <strong>CDIX<\/strong> operating platform, anchored by its subsidiary Nova Ortho and Spine, continues to experience strong demand across its markets and currently operates below full capacity primarily due to working capital constraints rather than clinical or operational limitations.<\/p>\n<p style=\"text-align: justify\"><strong>CDIX<\/strong> is actively pursuing strategic initiatives to:<\/p>\n<p style=\"text-align: justify\">Expand working capital to support increased patient volume and procedural throughput<\/p>\n<p style=\"text-align: justify\">Reduce reliance on higher-cost financing structures<\/p>\n<p style=\"text-align: justify\">Accelerate accounts receivable conversion cycles<\/p>\n<p style=\"text-align: justify\">Enhance overall EBITDA generation and cash flow visibility<\/p>\n<p style=\"text-align: justify\"><strong>CDIX<\/strong> has demonstrated and proven the ability to deploy capital at a very high rate of return. Management believes that improving access to cost-efficient growth capital will allow <strong>CDIX<\/strong> to materially increase utilization rates and unlock embedded operating leverage across its platform.<\/p>\n<p style=\"text-align: justify\">The OTCQX upgrade represents an important step in the <strong>CDIX<\/strong> broader capital markets strategy, which includes pursuing a future uplisting to a national securities exchange, such as the NYSE American or Nasdaq Capital Market, subject to meeting applicable listing requirements.<\/p>\n<p style=\"text-align: justify\"><strong>For more information on CDIX visit:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/pr.report\/geg3\">https:\/\/cardifflexington.com\/<\/a><\/p>\n<p style=\"text-align: justify\"><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"mailto:investorsrelations@cardifflexington.com\">investorsrelations@cardifflexington.com<\/a><\/p>\n<p style=\"text-align: justify\">DISCLAIMER: <a rel=\"nofollow\" href=\"https:\/\/corporateads.com\/disclaimer\/\">https:\/\/corporateads.com\/disclaimer\/<\/a><\/p>\n<p style=\"text-align: justify\"><em>Disclosure listed on the CorporateAds website<\/em><\/p>\n<p class=\"caps\"><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Cardiff Lexington Corporation (CDIX)<br \/><strong>Contact Person:<\/strong> Alex Cunningham, CEO<br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href='http:\/\/www.universalpressrelease.com\/?pr=high-patient-volume-expected-at-new-surgery-center-for-specialized-healthcare-provider-expanding-throughout-southeast-and-midatlantic-region-cardiff-lexington-corporation-stock-symbol-cdix'>Send Email<\/a><br \/><strong>Phone:<\/strong> (800) 628-2100<br \/><strong>Address:<\/strong>3753 Howard Hughes Parkway Suite 200  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV 89169<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"https:\/\/cardifflexington.com\/\" target=\"_blank\">https:\/\/cardifflexington.com\/<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.getnews.info\/press_stat.php?pr=high-patient-volume-expected-at-new-surgery-center-for-specialized-healthcare-provider-expanding-throughout-southeast-and-midatlantic-region-cardiff-lexington-corporation-stock-symbol-cdix\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>$CDIX Now Operates a Total of 12 Surgical Centers Dedicated to Orthopedics, Spine Care and Pain Management Focus on Acquiring and Building Middle-Market Niche Health Care Clinics, Primarily in Orthopedics,<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/538342"}],"collection":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/comments?post=538342"}],"version-history":[{"count":0,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/538342\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/media?parent=538342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/categories?post=538342"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/tags?post=538342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}